US FDA Outlines Agenda For Cybersecurity Workshop
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration plans to look back at cybersecurity issues it has faced over the past year and address challenges medical device companies will face in postmarket management and risk assessment of cybersecurity threats going forward at a public meeting later this month.